Drug Repositioning Market
1 Introduction to Research & Analysis Reports
1.1 Drug Repositioning Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Repositioning Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Repositioning Overall Market Size
2.1 Global Drug Repositioning Market Size: 2021 VS 2028
2.2 Global Drug Repositioning Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Repositioning Players in Global Market
3.2 Top Global Drug Repositioning Companies Ranked by Revenue
3.3 Global Drug Repositioning Revenue by Companies
3.4 Top 3 and Top 5 Drug Repositioning Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drug Repositioning Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repositioning Players in Global Market
3.6.1 List of Global Tier 1 Drug Repositioning Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Repositioning Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drug Repositioning Market Size Markets, 2021 & 2028
4.1.2 Generic Drugs
4.1.3 Clinical Trial Failed Drugs
4.2 By Type - Global Drug Repositioning Revenue & Forecasts
4.2.1 By Type - Global Drug Repositioning Revenue, 2017-2022
4.2.2 By Type - Global Drug Repositioning Revenue, 2023-2028
4.2.3 By Type - Global Drug Repositioning Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drug Repositioning Market Size, 2021 & 2028
5.1.2 Cardiovascular Diseases
5.1.3 Mental Illness
5.1.4 Cancer
5.1.5 Others
5.2 By Application - Global Drug Repositioning Revenue & Forecasts
5.2.1 By Application - Global Drug Repositioning Revenue, 2017-2022
5.2.2 By Application - Global Drug Repositioning Revenue, 2023-2028
5.2.3 By Application - Global Drug Repositioning Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drug Repositioning Market Size, 2021 & 2028
6.2 By Region - Global Drug Repositioning Revenue & Forecasts
6.2.1 By Region - Global Drug Repositioning Revenue, 2017-2022
6.2.2 By Region - Global Drug Repositioning Revenue, 2023-2028
6.2.3 By Region - Global Drug Repositioning Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drug Repositioning Revenue, 2017-2028
6.3.2 US Drug Repositioning Market Size, 2017-2028
6.3.3 Canada Drug Repositioning Market Size, 2017-2028
6.3.4 Mexico Drug Repositioning Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drug Repositioning Revenue, 2017-2028
6.4.2 Germany Drug Repositioning Market Size, 2017-2028
6.4.3 France Drug Repositioning Market Size, 2017-2028
6.4.4 U.K. Drug Repositioning Market Size, 2017-2028
6.4.5 Italy Drug Repositioning Market Size, 2017-2028
6.4.6 Russia Drug Repositioning Market Size, 2017-2028
6.4.7 Nordic Countries Drug Repositioning Market Size, 2017-2028
6.4.8 Benelux Drug Repositioning Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drug Repositioning Revenue, 2017-2028
6.5.2 China Drug Repositioning Market Size, 2017-2028
6.5.3 Japan Drug Repositioning Market Size, 2017-2028
6.5.4 South Korea Drug Repositioning Market Size, 2017-2028
6.5.5 Southeast Asia Drug Repositioning Market Size, 2017-2028
6.5.6 India Drug Repositioning Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drug Repositioning Revenue, 2017-2028
6.6.2 Brazil Drug Repositioning Market Size, 2017-2028
6.6.3 Argentina Drug Repositioning Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drug Repositioning Revenue, 2017-2028
6.7.2 Turkey Drug Repositioning Market Size, 2017-2028
6.7.3 Israel Drug Repositioning Market Size, 2017-2028
6.7.4 Saudi Arabia Drug Repositioning Market Size, 2017-2028
6.7.5 UAE Drug Repositioning Market Size, 2017-2028
7 Players Profiles
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Drug Repositioning Major Product Offerings
7.1.4 Teva Drug Repositioning Revenue in Global Market (2017-2022)
7.1.5 Teva Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Drug Repositioning Major Product Offerings
7.2.4 Novartis Drug Repositioning Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Mylan
7.3.1 Mylan Corporate Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Drug Repositioning Major Product Offerings
7.3.4 Mylan Drug Repositioning Revenue in Global Market (2017-2022)
7.3.5 Mylan Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Drug Repositioning Major Product Offerings
7.4.4 Johnson & Johnson Drug Repositioning Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Drug Repositioning Major Product Offerings
7.5.4 Pfizer Drug Repositioning Revenue in Global Market (2017-2022)
7.5.5 Pfizer Key News
7.6 Bausch Health
7.6.1 Bausch Health Corporate Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Drug Repositioning Major Product Offerings
7.6.4 Bausch Health Drug Repositioning Revenue in Global Market (2017-2022)
7.6.5 Bausch Health Key News
7.7 GSK
7.7.1 GSK Corporate Summary
7.7.2 GSK Business Overview
7.7.3 GSK Drug Repositioning Major Product Offerings
7.7.4 GSK Drug Repositioning Revenue in Global Market (2017-2022)
7.7.5 GSK Key News
7.8 ChemRar Group
7.8.1 ChemRar Group Corporate Summary
7.8.2 ChemRar Group Business Overview
7.8.3 ChemRar Group Drug Repositioning Major Product Offerings
7.8.4 ChemRar Group Drug Repositioning Revenue in Global Market (2017-2022)
7.8.5 ChemRar Group Key News
7.9 Glenmark
7.9.1 Glenmark Corporate Summary
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Drug Repositioning Major Product Offerings
7.9.4 Glenmark Drug Repositioning Revenue in Global Market (2017-2022)
7.9.5 Glenmark Key News
7.10 Fujifilm
7.10.1 Fujifilm Corporate Summary
7.10.2 Fujifilm Business Overview
7.10.3 Fujifilm Drug Repositioning Major Product Offerings
7.10.4 Fujifilm Drug Repositioning Revenue in Global Market (2017-2022)
7.10.5 Fujifilm Key News
7.11 Dr. Reddy
7.11.1 Dr. Reddy Corporate Summary
7.11.2 Dr. Reddy Business Overview
7.11.3 Dr. Reddy Drug Repositioning Major Product Offerings
7.11.4 Dr. Reddy Drug Repositioning Revenue in Global Market (2017-2022)
7.11.5 Dr. Reddy Key News
7.12 R-Pharma
7.12.1 R-Pharma Corporate Summary
7.12.2 R-Pharma Business Overview
7.12.3 R-Pharma Drug Repositioning Major Product Offerings
7.12.4 R-Pharma Drug Repositioning Revenue in Global Market (2017-2022)
7.12.5 R-Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Drug Repositioning Market Opportunities & Trends in Global Market
Table 2. Drug Repositioning Market Drivers in Global Market
Table 3. Drug Repositioning Market Restraints in Global Market
Table 4. Key Players of Drug Repositioning in Global Market
Table 5. Top Drug Repositioning Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drug Repositioning Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drug Repositioning Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drug Repositioning Product Type
Table 9. List of Global Tier 1 Drug Repositioning Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drug Repositioning Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Drug Repositioning Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drug Repositioning Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drug Repositioning Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Drug Repositioning Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drug Repositioning Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drug Repositioning Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Drug Repositioning Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drug Repositioning Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drug Repositioning Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drug Repositioning Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drug Repositioning Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Drug Repositioning Product Offerings
Table 32. Teva Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Drug Repositioning Product Offerings
Table 35. Novartis Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Drug Repositioning Product Offerings
Table 38. Mylan Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Drug Repositioning Product Offerings
Table 41. Johnson & Johnson Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Drug Repositioning Product Offerings
Table 44. Pfizer Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 45. Bausch Health Corporate Summary
Table 46. Bausch Health Drug Repositioning Product Offerings
Table 47. Bausch Health Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 48. GSK Corporate Summary
Table 49. GSK Drug Repositioning Product Offerings
Table 50. GSK Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 51. ChemRar Group Corporate Summary
Table 52. ChemRar Group Drug Repositioning Product Offerings
Table 53. ChemRar Group Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 54. Glenmark Corporate Summary
Table 55. Glenmark Drug Repositioning Product Offerings
Table 56. Glenmark Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 57. Fujifilm Corporate Summary
Table 58. Fujifilm Drug Repositioning Product Offerings
Table 59. Fujifilm Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 60. Dr. Reddy Corporate Summary
Table 61. Dr. Reddy Drug Repositioning Product Offerings
Table 62. Dr. Reddy Drug Repositioning Revenue (US$, Mn), (2017-2022)
Table 63. R-Pharma Corporate Summary
Table 64. R-Pharma Drug Repositioning Product Offerings
Table 65. R-Pharma Drug Repositioning Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Drug Repositioning Segment by Type in 2021
Figure 2. Drug Repositioning Segment by Application in 2021
Figure 3. Global Drug Repositioning Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Drug Repositioning Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drug Repositioning Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drug Repositioning Revenue in 2021
Figure 8. By Type - Global Drug Repositioning Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drug Repositioning Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drug Repositioning Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drug Repositioning Revenue Market Share, 2017-2028
Figure 12. US Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drug Repositioning Revenue Market Share, 2017-2028
Figure 16. Germany Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 17. France Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drug Repositioning Revenue Market Share, 2017-2028
Figure 24. China Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 28. India Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drug Repositioning Revenue Market Share, 2017-2028
Figure 30. Brazil Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drug Repositioning Revenue Market Share, 2017-2028
Figure 33. Turkey Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drug Repositioning Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch Health Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GSK Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ChemRar Group Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Glenmark Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Fujifilm Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Dr. Reddy Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. R-Pharma Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
